|
US2018093032A1
|
|
Targeted apheresis using binding agents or ligands immobilized on membranes
|
|
US2013115270A1
|
|
Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseases
|
|
US2013101663A1
|
|
Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseases
|
|
US2013115269A1
|
|
Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseases
|
|
US2013068691A1
|
|
Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
|
|
US2012231066A1
|
|
Multi-drug liposomes to treat tumors
|
|
US2012215150A1
|
|
Treatment of pre-eclampsia using targeted apheresis
|
|
US2010086585A1
|
|
Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseases
|
|
US2010167306A1
|
|
Rapid test for glycated albumin in saliva
|
|
US2009042237A1
|
|
Aptamer based point-of-care test for glycated albumin
|
|
US2009041837A1
|
|
Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseases
|
|
US7799327B2
|
|
Autoantibodies utilized as carrier agents for pharmaceutical compounds used in cancer treatment
|
|
GB117536A
|
|
A New or Improved Taper Turning Box Tool for use on Capstan and Automatic Machines.
|
